HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cosmetics user fees a potential solution to FDA budget restraints -- agency.

This article was originally published in The Rose Sheet

Executive Summary

COSMETICS USER FEES A POTENTIAL SOLUTION TO FDA FISCAL RESTRAINTS as the agency grapples with reduced operating budgets. Currently, user fees fund the color additive certification program for foods and cosmetics operated within the agency's Center for Food Safety & Applied Nutrition. Any additional fees would most likely be dedicated to the Office of Cosmetics & Colors' day-to-day operations. Discussions regarding the institution of new fees are ongoing and are part of an overall review of potential cost-cutting alternatives for the agency. FDA and the Cosmetic, Toiletry and Fragrance Association have met on a number of occasions to discuss several solutions, including the user fee option and the transfer of the cosmetics office from CFSAN to the Center for Drug Evaluation & Research.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005186

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel